Its relapsing nature was noted in the 20th century [3] while the discovery of highly-specific anti-aquaporin-4 (AQP4) antibodies established NMO as a distinct disease [4], which required the presence of optic neuritis and myelitis for diagnosis [5]. The gene discussed is AQP4; the disease is myelitis.